Search

This document provides information about a clinical trial for the treatment of acute immune thrombocytopenic purpura (ITP) in children. The trial aims to enroll 102 participants between the ages of 1 and 18 and will focus on patients who have been diagnosed with acute ITP based on clinical manifestations and laboratory investigations. The trial will investigate the use of corticosteroids, specifically methylprednisolone therapy, in the treatment of ITP in children. The primary contact for the study is Shereen Hassan Abd-Elrady, and the principal investigator is Azza Ahmed El-Tayab. [Extracted from the article]